Transcoronary bone marrow-derived progenitor cells in a child with myocardial infarction: first pediatric experience.

Background: Recent advances in stem cell therapy to restore cardiac function have great promise for patients with congestive heart failure after myocardial infarction in an adult population.

Objective: We examined the benefits of bone marrow-derived progenitor cells treatment modality for the pediatric patient.

Methods And Results: We present our first case of transcoronary autologous stem cell transplantation in a 9-year-old girl with refractory congestive heart failure secondary to myocardial infarction 1 year after transcatheter revascularization.